The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Centessa Pharmaceuticals plc ADR shares valued at $175,270 were sold by Weinhoff Gregory M on Feb 25 ’25. At $15.25 per share, Weinhoff Gregory M sold 11,494 shares. The insider’s holdings dropped to 134,021 shares worth approximately $2.02 million following the completion of this transaction.
Also, Weinhoff Gregory M purchased 11,494 shares, netting a total of over 175,270 in proceeds.
Before that, SAHA SAURABH had sold 55,000 shares from its account. In a trade valued at $876,088, the Chief Executive Officer traded Centessa Pharmaceuticals plc ADR shares for $15.93 each. Upon closing the transaction, the insider’s holdings decreased to 55,000 shares, worth approximately $4.99 million.
As published in their initiating research note from TD Cowen on January 07, 2025, Centessa Pharmaceuticals plc ADR [CNTA] has been a Buy. Analysts at Morgan Stanley upgraded the stock from ‘”an Equal-weight”‘ to ‘”an Overweight”‘ outlook in a report released in mid September. As of September 19, 2024, B. Riley Securities has initiated its “Buy” rating for CNTA. Earlier on July 18, 2024, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for CNTA stock.
Analyzing CNTA Stock Performance
During the last five days, there has been a drop of approximately -10.09%. Over the course of the year, Centessa Pharmaceuticals plc ADR shares have dropped approximately -10.09%. Shares of the company reached a 52-week high of $19.09 on 02/07/25 and a 52-week low of $14.44 on 01/14/25. A 50-day SMA is recorded $16.65, while a 200-day SMA reached $13.87. Nevertheless, trading volume fell to 0.77 million shares from 0.7 million shares the previous day.
Support And Resistance Levels for Centessa Pharmaceuticals plc ADR (CNTA)
According to the 24-hour chart, there is a support level at 14.65, which, if violated, would cause prices to drop to 14.25. In the upper region, resistance lies at 15.83. The next price resistance is at 16.61. RSI (Relative Strength Index) is 39.14 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.19, which suggests the price will decrease in the coming days. Percent R is at 92.75%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
